The offering includes one share and one-third of a warrant per unit, with an exercise price set at $11.50. Underwriters hold a 45-day window to purchase an additional 3 million units to manage potential over-allotments. While the firm currently lacks a specific business combination target, it intends to scout opportunities across any sector or industry. The company has moved to list its shares on the New York Stock Exchange under the ticker symbol VII.